Legal Status
Legal Status
Notice
Advisory Committees; Notice of Meetings
A Notice by the Food and Drug Administration on
Document Details
Information about this document as published in the Federal Register.
- Printed version:
- Publication Date:
- 12/12/2000
- Agencies:
- Food and Drug Administration
- Document Type:
- Notice
- Document Citation:
- 65 FR 77636
- Page:
- 77636-77639 (4 pages)
- Document Number:
- 00-31589
Document Details
-
Enhanced Content - Table of Contents
This tables of contents is a navigational tool, processed from the headings within the legal text of Federal Register documents. This repetition of headings to form internal navigation links has no substantive legal effect.
Enhanced Content - Table of Contents
-
Enhanced Content - Submit Public Comment
- This feature is not available for this document.
Enhanced Content - Submit Public Comment
-
Enhanced Content - Read Public Comments
- This feature is not available for this document.
Enhanced Content - Read Public Comments
-
Enhanced Content - Sharing
- Shorter Document URL
- https://www.federalregister.gov/d/00-31589 https://www.federalregister.gov/d/00-31589
Enhanced Content - Sharing
-
Enhanced Content - Document Tools
These tools are designed to help you understand the official document better and aid in comparing the online edition to the print edition.
-
These markup elements allow the user to see how the document follows the Document Drafting Handbook that agencies use to create their documents. These can be useful for better understanding how a document is structured but are not part of the published document itself.
Display Non-Printed Markup Elements
Enhanced Content - Document Tools
-
-
Enhanced Content - Developer Tools
This document is available in the following developer friendly formats:
- JSON: Normalized attributes and metadata
- XML: Original full text XML
- MODS: Government Publishing Office metadata
More information and documentation can be found in our developer tools pages.
Enhanced Content - Developer Tools
Published Document
This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.
AGENCY:
Food and Drug Administration, HHS.
ACTION:
Notice.
SUMMARY:
The Food and Drug Administration (FDA) is announcing a tentative schedule of forthcoming meetings of its public advisory committees for 2001. During 1991, at the request of the Commissioner of Food and Drugs (the Commissioner), the Institute of Medicine (the IOM) conducted a study of the use of FDA's advisory committees. In its final report, one of the IOM's recommendations was for the agency to publish an annual tentative schedule of its meetings in the Federal Register. This publication implements the IOM's recommendation.
Start Further InfoFOR FURTHER INFORMATION CONTACT:
Donna M. Combs, Committee Management Office (HFA-306), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-5496.
End Further Info End Preamble Start Supplemental InformationSUPPLEMENTARY INFORMATION:
The IOM, at the request of the Commissioner, undertook a study of the use of FDA's advisory committees. In its final report in 1992, one of the IOM's recommendations was for FDA to adopt a policy of publishing an advance yearly schedule of its upcoming public advisory committee meetings in the Start Printed Page 77637 Federal Register and FDA implemented the recommendation. The annual publication of tentatively scheduled advisory committee meetings will provide both advisory committee members and the public with the opportunity, in advance, to schedule attendance at FDA's upcoming advisory committee meetings. Since the schedule is tentative, amendments to this notice will not be published in the Federal Register. However, changes to the schedule will be posted on the FDA Advisory Committees' home page located at www.fda.gov/oc/advisory/default.htm. The FDA will continue to publish a Federal Register notice 15 days in advance of each upcoming advisory committee meeting, to announce the meeting (21 CFR 14.20).
The following list announces FDA's tentatively scheduled advisory committee meetings for 2001. You may also obtain up-to-date meeting information by calling the Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area):
Committee Name | Dates of Meetings | Advisory Committee 5-Digit Information Line Code |
---|---|---|
OFFICE OF THE COMMISSIONER | ||
Science Board to the Food and Drug Administration | April 13 November 16 | 12603 |
CENTER FOR BIOLOGICS EVALUATION AND RESEARCH | ||
Allergenic Products Advisory Committee | March 5 October 29 | 12388 |
Biological Response Modifiers Advisory Committee | January 18-19 April 5-6 July 12-13 October 25-26 | 12389 |
Blood Products Advisory Committee | March 15-16 July 26-27 September 20-21 December 13-14 | 19516 |
Transmissible Spongiform Encephalopathies Advisory Committee | January 18-19 June 28-29 October 25-26 | 12392 |
Vaccines and Related Biological Products Advisory Committee | January 30-31 March 8-9 May 16-17 September 13-14 November 28-29 | 12391 |
CENTER FOR DRUG EVALUATION AND RESEARCH | ||
Advisory Committee for Pharmaceutical Science | April 23-24 August 13-14 October 29-30 | 12539 |
Advisory Committee for Reproductive Health Drugs | June 1 | 12537 |
Anesthetic and Life Support Drugs Advisory Committee | January 25-26 May 10-11 September 13-14 | 12529 |
Anti-Infective Drugs Advisory Committee | January 29-30 | 12530 |
Antiviral Drugs Advisory Committee | January 11 April 26-27 July 23-24 October 22-23 December 6-7 | 12531 |
Arthritis Advisory Committee | February 7-9 April 19-20 August 16-17 October 11-12 December 6-7 | 12532 |
Cardiovascular and Renal Drugs Advisory Committee | February 8-9 May 17-18 October 18-19 | 12533 |
Dermatologic and Ophthalmic Drugs Advisory Committee | February 5 June 5 August 14 September 18 December 9-10 | 12534 |
Drug Abuse Advisory Committee | No meetings are planned | 12535 |
Endocrinologic and Metabolic Drugs Advisory Committee | February 22-23 April 26-27 July 26-27 September 20-21 November 8-9 | 12536 |
Gastrointestinal Drugs Advisory Committee | March 29-30 | 12538 |
Medical Imaging Drugs Advisory Committee | March 1 July 2 | 12540 |
Start Printed Page 77638 | ||
Nonprescription Drugs Advisory Committee | May 10-11 | 12541 |
Oncologic Drugs Advisory Committee | March 13-14 June 7-8 | 12542 |
Peripheral and Central Nervous System Drugs Advisory Committee | March 13-15 | 12543 |
Pharmacy Compounding Advisory Committee | March 29-30 June 28-29 September 13-14 | 12440 |
Psychopharmacologic Drugs Advisory Committee | February 14-15 | 12544 |
Pulmonary-Allergy Drugs Advisory Committee | January 18-19 April 26-27 September 6-7 | 12545 |
CENTER FOR FOOD SAFETY AND APPLIED NUTRITION | ||
Food Advisory Committee | April 23-24 September 24-25 | 10564 |
CENTER FOR DEVICES AND RADIOLOGICAL HEALTH | ||
Device Good Manufacturing Practice Advisory Committee | No meetings are planned | 12398 |
Medical Devices Advisory Committee | ||
Anesthesiology and Respiratory Therapy Devices Panel | June 14-15 | 12624 |
Circulatory System Devices Panel | February 5 April 2-3 June 25-26 September 10-11 December 3-4 | 12625 |
Clinical Chemistry and Clinical Toxicology Devices Panel | January 17 May 9 July 11 October 24-25 December 5-6 | 12514 |
Dental Products Panel | April 3-4 August 14-15 November 13-14 | 12518 |
Dispute Resolution Panel | Will meet as needed | 10232 |
Ear, Nose, and Throat Devices Panel | February 22-23 June 11-12 October 11-12 | 12522 |
Gastroenterology-Urology Devices Panel | March 9 June 29 September 24-25 December 10-11 | 12523 |
General and Plastic Surgery Devices Panel | February 7 May 15-16 September 24-25 December 10-11 | 12519 |
General Hospital and Personal Use Devices Panel | February 12-13 May 17-18 August 2-3 November 1-2 | 12520 |
Hematology and Pathology Devices Panel | February 26 April 23 July 30 October 8 | 12515 |
Immunology Devices Panel | March 16 June 15 September 14 December 3 | 12516 |
Microbiology Devices Panel | March 8-9 July 19-20 October 25-26 December 6-7 | 12517 |
Molecular and Clinical Genetics Panel | March 9 June 8 September 7 December 7 | 10231 |
Neurological Devices Panel | February 8-9 May 17-18 November 15-16 | 12513 |
Obstetrics-Gynecology Devices Panel | January 29-30 April 30-May 1 July 16-17 October 15-16 | 12524 |
Start Printed Page 77639 | ||
Ophthalmic Devices Panel | March 15-16 May 17-18 July 19-20 September 20-21 November 29-30 | 12396 |
Orthopaedic and Rehabilitation Devices Panel | January 18-19 May 10-11 August 9-10 November 1-2 | 12521 |
Radiological Devices Panel | February 5 May 14 August 13 November 5 | 12526 |
National Mammography Quality Assurance Advisory Committee | April 23 September 10 | 12397 |
Technical Electronic Product Radiation Safety Standards Committee | May 16-17 | 12399 |
CENTER FOR VETERINARY MEDICINE | ||
Veterinary Medicine Advisory Committee | February 20-21 September 12-13 | 12548 |
NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH | ||
Advisory Committee on Special Studies Relating to the Possible Long-Term Health Effects of Phenoxy Herbicides and Contaminants | December 6-7 May 10-11 | 12560 |
Science Board to the National Center for Toxicological Research | June 7-8 | 12559 |
Dated: December 5, 2000.
Linda A. Suydam,
Senior Associate Commissioner.
[FR Doc. 00-31589 Filed 12-11-00; 8:45 am]
BILLING CODE 4160-01-F